Laurion Capital Management LP raised its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 1,927.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 57,665 shares of the company’s stock after acquiring an additional 54,821 shares during the quarter. Laurion Capital Management LP’s holdings in U.S. Physical Therapy were worth $6,839,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of USPH. BlackRock Inc. increased its stake in shares of U.S. Physical Therapy by 11.5% in the third quarter. BlackRock Inc. now owns 1,950,274 shares of the company’s stock valued at $231,302,000 after buying an additional 201,866 shares during the period. Renaissance Technologies LLC increased its stake in shares of U.S. Physical Therapy by 4.6% in the second quarter. Renaissance Technologies LLC now owns 653,100 shares of the company’s stock valued at $62,698,000 after buying an additional 28,600 shares during the period. Northern Trust Corp increased its stake in shares of U.S. Physical Therapy by 10.3% in the second quarter. Northern Trust Corp now owns 217,737 shares of the company’s stock valued at $20,903,000 after buying an additional 20,295 shares during the period. Bank of New York Mellon Corp increased its stake in shares of U.S. Physical Therapy by 3.1% in the third quarter. Bank of New York Mellon Corp now owns 185,318 shares of the company’s stock valued at $21,979,000 after buying an additional 5,527 shares during the period. Finally, Russell Investments Group Ltd. increased its stake in shares of U.S. Physical Therapy by 5.8% in the second quarter. Russell Investments Group Ltd. now owns 151,750 shares of the company’s stock valued at $14,571,000 after buying an additional 8,325 shares during the period. 99.58% of the stock is owned by hedge funds and other institutional investors.

Several research analysts have recently issued reports on USPH shares. Cantor Fitzgerald upped their price objective on U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. TheStreet downgraded U.S. Physical Therapy from a “b” rating to a “c+” rating in a research note on Friday, November 2nd. Four research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $113.67.

U.S. Physical Therapy stock opened at $110.64 on Friday. U.S. Physical Therapy, Inc. has a 1 year low of $70.10 and a 1 year high of $129.65. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.93 and a quick ratio of 1.93. The company has a market capitalization of $1.39 billion, a PE ratio of 53.19, a PEG ratio of 3.81 and a beta of 1.21.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.06. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. The company had revenue of $113.10 million during the quarter, compared to the consensus estimate of $112.79 million. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.55 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Friday, November 9th will be given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date is Thursday, November 8th. U.S. Physical Therapy’s dividend payout ratio is presently 44.23%.

In other U.S. Physical Therapy news, Director Mark J. Brookner sold 500 shares of the stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $118.50, for a total transaction of $59,250.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Lawrance W. Mcafee sold 3,100 shares of the stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $113.29, for a total transaction of $351,199.00. The disclosure for this sale can be found here. Insiders have sold a total of 8,100 shares of company stock valued at $927,949 in the last three months. Insiders own 2.50% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/laurion-capital-management-lp-boosts-stake-in-u-s-physical-therapy-inc-usph/2667901.html.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Story: What are trading strategies for the 52-week high/low?

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.